pISSN 1226-6051
eISSN 2508-786X

Table. 7.

Table. 7.

Comparisons of 2nd line antifungal agents in therapeutic drug monitoring (TDM) vs. non-TDM groups

TDM (n = 7)non-TDM (n = 15)Total (n = 22)p-value
Liposomal amphotericin B, N(%)4 (57.1)10 (66.7)14 (63.6)1.000
Caspofungin, N(%)2 (28.6)2 (13.3)4 (18.2)0.565
Combined treatment, N(%)1 (14.3)3 (20.0)4 (18.2)1.000

Data are the No. (%)

From the Fisher’s exact test

Korean J Clin Pharm 2019;29:89-100 https://doi.org/10.24304/kjcp.2019.29.2.89
© 2019 Korean J Clin Pharm